Conan G. Kinsey
( out of 86 reviews )

Conan G. Kinsey, MD, PhD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
Salt Lake City
801-587-4700

  • Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    5.0 /5
    ( out of 86 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    November 09, 2024
    HUNTSMAN CANCER CENTER

    thank you

    October 17, 2024
    HUNTSMAN CANCER CENTER

    Dr. Kinsey is the best! He works well with my medical team, is very responsive and cooperative. Not only does he listen to my concerns but his explanations are easy to understand and relatable. I just love him!!!!

    October 04, 2024
    HUNTSMAN CANCER CENTER

    He was prepared. He'd looked at my extensive medical history and was well prepared. He even reviewed the stuff I brought with me same day.

    September 21, 2024
    HUNTSMAN CANCER CENTER

    DR. Kinsey listened to me & helped me make the right decision for my care. He made sure I had the best DR for my kind of surgery. I trust him completely.

    September 14, 2024
    HUNTSMAN CANCER CENTER

    Excellent Dr

    September 01, 2024
    HUNTSMAN CANCER CENTER

    Dr. Kinsey is positive and friendly. He answers all my questions and is never in a rush. I am so lucky he's my doctor.

    July 08, 2024
    HUNTSMAN CANCER CENTER

    Dr Kinsey has consistently provided the top tier of care throughout the course of my medical treatment.

    June 15, 2024
    HUNTSMAN CANCER CENTER

    Dr Kinsey is the most wonderful doctor I have ever met. Not only is he an ultimate professional but also an extremely knowledgeable doctor in his field of practice. I will go back to him time and time again.

    June 03, 2024
    HUNTSMAN CANCER CENTER

    Highly recommend

    See More Patient Comments

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Postdoctoral Fellowship Hematology/Oncology - Huntsman Cancer Institute Postdoctoral Fellow
    Fellowship Hematology/Oncology - Huntsman Cancer Institute Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Professional Medical Genetics and Medicine - University of Rochester School of Medicine and Dentistry M.D., Ph.D.
    Undergraduate Cell Biology/Biochemistry - Bucknell University B.S.

    Selected Publications

    Journal Article

    1. Ghazi PC, OToole KT, Srinivas Boggaram S, Scherzer MT, Silvis MR, Zhang Y, Bogdan M, Smith BD, Lozano G, Flynn DL, Snyder EL, Kinsey CG, McMahon M (2024). Inhibition of ULK1/2 and KRAS(G12C) controls tumor growth in preclinical models of lung cancer. Elife, 13. (Read full article)
    2. Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Murphy B, Hackett CS, Dupuy AJ, Chmura SA, van der Weyden L, Newberg JY, Liu A, Mann K, Rust AG, Weiss WA, Kinsey CG, Adams DJ, Grossmann A, Mann MB, McMahon M (2021). Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer Res, 82(22), 4261-4273. (Read full article)
    3. Truong A, Yoo JH, Scherzer MT, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi PC, Onken MD, Blumer KJ, Odelberg SJ, McMahon M (2020). Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clin Cancer Res, 26(23), 6374-6386. (Read full article)
    4. Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M (2019). Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Rep, 32(5), 107994. (Read full article)
    5. Kinsey C, Balakrishnan V, ODell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H (2014). Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep, 7(4), 1143-55. (Read full article)
    6. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H (2008). Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature, 453(7198), 1112-6. (Read full article)
    7. Kinsey CG, Bussolati G, Bosco M, Kimura T, Pizzorno MC, Chernin MI, Cassoni P, Novak JF (2007). Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med, 11(1), 96-110. (Read full article)
    8. Takahashi M, Chernin MI, Yamamoto O, Tonzetich J, Kinsey CG, Novak JF (2002). Transformation of MC3T3-E1 cells following stress and transfection with pSV2neo plasmid. Anticancer Res, 22(2A), 585-98. (Read full article)

    Review

    1. Foth M, Garrido-Laguna I, Kinsey CG (2021). Therapeutic Targeting of Autophagy in Pancreatic Cancer. [Review]. Surg Oncol Clin N Am, 30(4), 709-718. (Read full article)
    2. Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S (2018). Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. [Review]. J Gastrointest Oncol, 9(6), 1014-1026. (Read full article)

    Book Chapter

    1. Vaishnavi A, Kinsey CG, McMahon M (2023). Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse. In Cold Spring Harb Perspect Med. United States. (Read full article)
    2. Gilcrease GW, Kinsey C, Stenehjem D (2015). Environmental and genetic risk factors in hepatocellular carcinoma. In Torre A, Uscanga L (Eds.), Medicina Individualizada De La Evidencia A La Práctica Clínica (pp. 155-62). Permanyer México.

    Research Lab

    Lab link

  • News & Podcasts

    News

    Huntsman Cancer Institute News